Resonance Health Ltd has released a press release.
Resignation of CEO & Management Changes
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Resonance Health
- Filing of Patent Application
- R&D Update - Molecular Medicine ASO Project
- Appendix 4C - quarterly
- Resonance Health: HepaFat-AI Receives CE Marking
- HepaFat-AI Receives TGA Approval
Later from Resonance Health
- Appointment of Managing Director
- Appointment of GM - Global Sales & Marketing
- New AI Medical Device
- Sales & Marketing Update
- Thalassaemia International Federation to Deploy FerriSmart
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health